您的位置: 首页 > 农业专利 > 详情页

Allogeneic cancer cell-based immunotherapy
专利权人:
Nozomi Yamazaki;Joseph D. Rosenblatt;Eckhard R. Podack
发明人:
Eckhard R. Podack,Koichi Yamazaki,Joseph D. Rosenblatt
申请号:
US12921151
公开号:
US08475785B2
申请日:
2009.03.03
申请国别(地区):
US
年份:
2013
代理人:
摘要:
Cell-based immunotherapy (e.g., immunization or vaccination) may be improved by frequent administration to a human subject of allogeneic cancer cells secreting a modified heat shock protein (e.g., gp96), depletion of B cells in the subject, or both. Antigen (e.g., epitope derived from neoantigen or tumor antigen of allogeneic or syngeneic cancer cells) may induce a specific immune response in the subject. For example, the epitope bound in an immunogenic complex with the secreted heat shock protein may be obtained from allogeneic cancer cells coexpressing both secreted gp96 and antigen, or from syngeneic cancer cells of the subject expressing only antigen.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充